2 options
New drug development : estimating entry from human clinical trials / Christopher P. Adams & Van V. Brantner.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- Adams, Christopher P.
- Series:
- Working paper (United States. Federal Trade Commission. Bureau of Economics) ; no. 262.
- Working paper ; no. 262
- Language:
- English
- Subjects (All):
- Drug development.
- Clinical trials.
- Drugs--Design.
- Drugs.
- Clinical Trials as Topic.
- Drug Design.
- Medical Subjects:
- Clinical Trials as Topic.
- Drug Design.
- Physical Description:
- 1 online resource.
- Place of Publication:
- [Washington, D.C.] : Bureau of Economics, Federal Trade Commission, [2003]
- Summary:
- This paper analyses a detailed data set on drugs in human clinical trials around the world between 1989 and 2002. The data provides information on the probabilities with which drugs successfully complete the different phases of the trials and the durations of successful completions.
- Notes:
- Title from PDF title screen (viewed Sept. 24, 2008).
- "July 7, 2003."
- Other Format:
- Adams, Christopher P. New drug development
- OCLC:
- 231761125
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.